Gainers
- InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.
- Onion Global Limited (NYSE:OG) gained 113.9% to $0.8556.
- ChemoCentryx, Inc. (NASDAQ:CCXI) gained 110% to $50.68 after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share in cash.
- Minerva Neurosciences, Inc. (NASDAQ:NERV) jumped 80% to $4.8300.
- Greenpro Capital Corp. (NASDAQ:GRNQ) rose 61.1% to $2.82 after climbing around 14% on Tuesday after climbing 28% on Wednesday.
- Missfresh Limited (NASDAQ:MF) shares surged 59.3% to $0.1834 after dropping 7% on Wednesday.
- Quhuo Limited (NASDAQ:QH) gained 51.8% to $0.4966.
- Yellow Corporation (NASDAQ:YELL) rose 44.1% to $6.79 after the company swung to a profit for the second quarter.
- Society Pass Incorporated (NASDAQ:SOPA) gained 42.8% to $2.6700 after reporting 2Q 2022 and 1H 2022 financial results.
- GreenLight Biosciences Holdings (NASDAQ:GRNA) shares gained 39.6% to $4.55 after jumping over 25% on Wednesday. Samsung Biologics and the company recently announced the completion of the first commercial-scale engineering run for the companies' mRNA production partnership.
- ZW Data Action Technologies Inc. (NASDAQ:CNET) surged 37.5% to $0.79. ZW Data Action Technologies recently collaborated with Forbes Global Alliance to build the Forbes China Group Digital Collection Platform to launch NFT Products and jointly operate the platform data.
- Global Blood Therapeutics, Inc. (NASDAQ:GBT) rose 36.5% to $46.31 following a report suggesting the company is attracting takeover interest. According to a Bloomberg report, citing people familiar with the matter, some large pharmaceutical companies are looking into a potential deal.
- Legacy Housing Corporation (NASDAQ:LEGH) rose 29.9% to $17.55. Legacy Housing will restate its 1st, 2nd, 3rd quarters unaudited interim financial statements for FY21, Reuters reported.
- Forge Global Holdings, Inc. (NYSE:FRGE) jumped 27.8% to $5.82. Forge Global is expected to report Q2 financial results on August 11, 2022.
- Molecular Data Inc. (NASDAQ:MKD) gained 26.3% to $0.7701.
- Waitr Holdings Inc. (NASDAQ:WTRH) surged 26% to $0.4267.
- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) gained 25.5% to $14.00 after the company reported better-than-expected Q2 EPS and sales results. The company also announced the FDA has lifted its partial clinical hold on the BCX9930 program.
- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) shares rose 25.5% to $0.1418 after gaining around 9% on Wednesday.
- Immunic, Inc. (NASDAQ:IMUX) gained 25% to $4.89 following Q2 results.
- NanoViricides, Inc. (NYSE:NNVC) jumped 23.5% to $3.04 after the company announced it has begun drug development to combat Monkeypox virus.
- Exela Technologies, Inc. (NASDAQ:XELA) rose 20.5% to $1.7594 after the company announced an update on its capital deployment strategy. Exela Technologies says the company has purchased $70 million of face value 2026 Senior Secured Notes at a discount with funds raised from equity. This will be the first contribution to the company's STS ("Serve the Shareholders") initiative.
- Ashford Inc. (NYSE:AINC) gained 20.1% to $16.78 following Q2 earnings.
- Staffing 360 Solutions, Inc. (NASDAQ:STAF) surged 20% to $3.8462.
- Synthetic Biologics, Inc. (NYSE:SYN) rose 19.4% to $1.77. Synthetic Biologics recently announced a $3 million private placement of convertible preferred stock.
- Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) gained 19.1% to $0.2650.
- TTM Technologies, Inc. (NASDAQ:TTMI) gained 18.5% to $16.01 following upbeat Q2 results.
- Precigen, Inc. (NASDAQ:PGEN) jumped 18.4% to $2.12.
- Exicure, Inc. (NASDAQ:XCUR) shares rose 18.1% to $2.35 after climbing around 27% on Wednesday.
- PagSeguro Digital Ltd. (NYSE:PAGS) climbed 17.8% to $14.41.
- Coinbase Global, Inc. (NASDAQ:COIN) gained 17% to $94.50 after the company announced a partnership with BlackRock.
- Rent-A-Center, Inc. (NASDAQ:RCII) climbed 16% to $29.49 following upbeat quarterly earnings.
- MercadoLibre, Inc. (NASDAQ:MELI) rose 15.9% to $1,032.06 following better-than-expected quarterly results.
- Ampio Pharmaceuticals, Inc. (NYSE:AMPE) rose 15.7% to $0.1196 after dipping around 34% on Wednesday.
- Applied DNA Sciences, Inc. (NASDAQ:APDN) gained 15.8% to $4.75 as the company reported pricing of $12 million upsized offering.
- Altice USA, Inc. (NYSE:ATUS) surged 15.5% to $11.17 following strong quarterly sales.
- Pintec Technology Holdings Limited (NASDAQ:PT) jumped 15.5% to $1.19.
- Sprouts Farmers Market, Inc. (NASDAQ:SFM) surged 15% to $31.24 following better-than-expected quarterly results.
- Amesite Inc. (NASDAQ:AMST) gained 14.6% to $0.4934.
- Insmed Incorporated (NASDAQ:INSM) jumped 13.7% to $24.76 following narrower-than-expected Q2 loss.
- Arcosa, Inc. (NYSE:ACA) jumped 13.4% to $58.18 after reporting upbeat Q2 results.
- Digital Brands Group, Inc. (NASDAQ:DBGI) rose 13.3% to $0.1360. Digital Brands Group, last month, received a determination letter from the Nasdaq stating that the Company has not regained compliance.
- ATI Inc. (NYSE:ATI) gained 11.5% to $28.26 after reporting strong quarterly results.
- Gol Linhas Aéreas Inteligentes S.A. (NYSE:GOL) gained 11.2% to $3.78 after the company reported preliminary traffic figures for July 2022.
- Advanced Drainage Systems, Inc. (NYSE:WMS) jumped 10.8% to $133.48 after the company reported better-than-expected Q1 EPS and sales results and issued FY23 sales guidance above estimates.
- Hecla Mining Company (NYSE:HL) gained 9.3% to $4.82 following upbeat Q2 results.
- Benitec Biopharma Inc. (NASDAQ:BNTC) rose 8.7% to $0.86.
- Installed Building Products, Inc. (NYSE:IBP) gained 7.7% to $105.32 following Q2 results.
- Huntington Ingalls Industries, Inc. (NYSE:HII) jumped 7.1% to $234.24 as the company reported a second-quarter sales and service revenue increase of 19.3% year-over-year to $2.662 billion, beating the consensus of $2.62 billion.
- American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) shares rose 6.3% to $0.1861.
- Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) rose 5% to $0.9227. The European Medicines Agency issued a positive opinion on Syros Pharmaceuticals’ application for orphan drug designation for tamibarotene for myelodysplastic syndrome (MDS).
- Novo Nordisk A/S (NYSE:NVO) rose 3.7% to $103.60. Novo Nordisk reported Q2 sales of DKK41.27 billion, +25% Y/Y (+15% on a constant currency basis).
